MAPT and Alzheimer disease: The main finding in the AD study was a significantly increased gingipain load in the MTG of AD patients compared to controls that correlated with tau and ubiquitin pathology and a small cohort of PD patient samples was included that had an RgpB load in the MTG comparable to the control group.